Cargando…

Combining predictive markers for severe COVID-19: Torquetenovirus DNA load and SARS-CoV-2 RNAemia

RATIONALE/OBJECTIVES: SARS-CoV-2 is the cause of worldwide COVID-19, which severity has been linked to the immune and inflammatory response. Here, we investigate Torquetenovirus (TTV) DNA load - a marker reflecting the intensity of the overall immune response - as well as SARS-CoV-2 RNAemia and IgM/...

Descripción completa

Detalles Bibliográficos
Autores principales:	Solis, Morgane, Gallais, Floriane, Garnier-Kepka, Sabrina, Lefebvre, Nicolas, Benotmane, Ilies, Ludes, Pierre-Olivier, Castelain, Vincent, Meziani, Ferhat, Caillard, Sophie, Collange, Olivier, Fafi-Kremer, Samira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861125/ https://www.ncbi.nlm.nih.gov/pubmed/35227970 http://dx.doi.org/10.1016/j.jcv.2022.105120

Ejemplares similares

Evaluation of the performance of SARS-CoV-2 serological tools and their positioning in COVID-19 diagnostic strategies
por: Velay, Aurelie, et al.
Publicado: (2020)

Molecular evolution of the SARS-CoV-2 omicron BA.2 variant in kidney transplant recipients with prolonged viral shedding
por: Caillard, Sophie, et al.
Publicado: (2023)

A fourth dose of the mRNA-1273 SARS-CoV-2 vaccine improves serum neutralization against the Delta variant in kidney transplant recipients
por: Benotmane, Ilies, et al.
Publicado: (2022)

Torque teno virus DNA load as a predictive marker of antibody response to a three-dose regimen of COVID-19 mRNA-based vaccine in lung transplant recipients
por: Gallais, Floriane, et al.
Publicado: (2022)

Pre-exposure prophylaxis with 300 mg Evusheld elicits limited neutralizing activity against the Omicron variant
por: Benotmane, Ilies, et al.
Publicado: (2022)

Persistence of SARS-CoV-2 antibodies in kidney transplant recipients
por: Benotmane, Ilies, et al.
Publicado: (2021)

Case Report: Evolution of Humoral and Cellular Immunity in Two COVID-19 Breakthrough Infections After BNT162b2 Vaccine
por: Gallais, Floriane, et al.
Publicado: (2022)

Neurologic Features in Severe SARS-CoV-2 Infection
por: Helms, Julie, et al.
Publicado: (2020)

Infection or a third dose of mRNA vaccine elicits neutralizing antibody responses against SARS-CoV-2 in kidney transplant recipients
por: Charmetant, Xavier, et al.
Publicado: (2022)

Weak anti–SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients
por: Benotmane, Ilies, et al.
Publicado: (2021)

Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine
por: Benotmane, Ilies, et al.
Publicado: (2021)

Outbreak of SARS-CoV-2 infection in a long-term care facility after COVID-19 BNT162b2 mRNA vaccination
por: Martinot, Martin, et al.
Publicado: (2021)

Inadequate Immune Humoral Response against JC Virus in Progressive Multifocal Leukoencephalopathy Non-Survivors
por: Solis, Morgane, et al.
Publicado: (2020)

Prediction of Vaccine Response and Development of a Personalized Anti-SARS-CoV-2 Vaccination Strategy in Kidney Transplant Recipients: Results from a Large Single-Center Study
por: Benotmane, Ilies, et al.
Publicado: (2022)

L’immunosuppression et le défaut d’immunogénicité des vaccins à ARNm limitent la protection des patients transplantés vaccinés selon le schéma standard : plaidoyer pour une 3(e) dose
por: Charmetant, X., et al.
Publicado: (2021)

Understanding torquetenovirus (TTV) as an immune marker
por: Gore, Edmund J., et al.
Publicado: (2023)

A rapid decline in the anti–receptor-binding domain of the SARS-CoV-2 spike protein IgG titer in kidney transplant recipients after tixagevimab–cilgavimab administration
por: Benotmane, Ilies, et al.
Publicado: (2022)

Torquetenovirus Serum Load and Long-Term Outcomes in Renal Transplant Recipients
por: Gore, Edmund J., et al.
Publicado: (2020)

Intrafamilial Exposure to SARS-CoV-2 Associated with Cellular Immune Response without Seroconversion, France
por: Gallais, Floriane, et al.
Publicado: (2021)

Editorial: Torquetenovirus: predictive biomarker or innocent bystander in pathogenesis
por: Tozetto-Mendoza, Tania Regina, et al.
Publicado: (2023)

COVID-19 in a kidney transplant recipient treated with eculizumab for atypical hemolytic uremic syndrome: a case report
por: Cognard, Noëlle, et al.
Publicado: (2021)

Plasma Torquetenovirus (TTV) microRNAs and severity of COVID-19
por: Stincarelli, Maria Alfreda, et al.
Publicado: (2022)

Prédiction de la sévérité de la COVID-19 par les biomarqueurs du syndrome de relargage cytokinique au sein d’une population de transplantés rénaux
por: Benotmane, I., et al.
Publicado: (2020)

Torquetenovirus detection in exosomes enriched vesicles circulating in human plasma samples
por: Martelli, Francesco, et al.
Publicado: (2018)

The vaginal Torquetenovirus titer varies with vaginal microbiota composition in pregnant women
por: Tozetto-Mendoza, Tania Regina, et al.
Publicado: (2022)

Torquetenovirus in pregnancy: Correlation with vaginal microbiome, metabolome and pro-inflammatory cytokines
por: Morselli, Sara, et al.
Publicado: (2022)

Rapid Antigen Test Combined with Chest Computed Tomography to Rule Out COVID-19 in Patients Admitted to the Emergency Department
por: Kepka, Sabrina, et al.
Publicado: (2021)

Delirium and encephalopathy in severe COVID-19: a cohort analysis of ICU patients
por: Helms, Julie, et al.
Publicado: (2020)

In Vitro and In Vivo Models for the Study of Human Polyomavirus Infection
por: Barth, Heidi, et al.
Publicado: (2016)

Viral load of Torquetenovirus correlates with Sano’s score and levels of total bilirubin and aspartate aminotransferase in Kawasaki disease
por: Spezia, Pietro Giorgio, et al.
Publicado: (2023)

Rapid resolution of cytokine release syndrome and favorable clinical course of severe COVID-19 in a kidney transplant recipient treated with tocilizumab
por: Gautier-Vargas, Gabriela, et al.
Publicado: (2020)

Torquetenovirus in saliva: A potential biomarker for SARS-CoV-2 infection?
por: Mendes-Correa, Maria C., et al.
Publicado: (2021)

Cellular and humoral immunity after the third dose of SARS-CoV-2 vaccine in patients treated with rituximab
por: Felten, Renaud, et al.
Publicado: (2022)

An unusually high substitution rate in transplant-associated BK polyomavirus in vivo is further concentrated in HLA-C-bound viral peptides
por: Domingo-Calap, Pilar, et al.
Publicado: (2018)

Association of high SARS-CoV-2 RNAemia with diabetes and mortality in critically ill COVID-19 patients
por: Monchi, Mehran, et al.
Publicado: (2022)

ICU re-organisation to face the first COVID-19 epidemic wave in a tertiary hospital
por: Collange, Olivier, et al.
Publicado: (2020)

SARS-CoV-2 RNAemia is associated with severe chronic underlying diseases but not with nasopharyngeal viral load
por: Berastegui-Cabrera, Judith, et al.
Publicado: (2021)

RNAemia Corresponds to Disease Severity and Antibody Response in Hospitalized COVID-19 Patients
por: Eberhardt, Kirsten Alexandra, et al.
Publicado: (2020)

Temporal Kinetics of RNAemia and Associated Systemic Cytokines in Hospitalized COVID-19 Patients
por: van Riel, Debby, et al.
Publicado: (2021)

372. Detection of SARS-CoV-2 RNAemia in Deceased Tissue Donors
por: Greenwald, Melissa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h87ck2043ne0cl6jlnu6jhaqmg